RGEN Q4 2025 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q4 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$198M+18.1% YoY

Gross Profit

$93M47.2% margin

Operating Income

$19M9.4% margin

Net Income

$13M6.7% margin

EPS (Diluted)

$0.23

QoQ Revenue Growth

+4.8%

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

$17M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$2.9B

Total Liabilities

$844M

Stockholders' Equity

$2.1B

Cash & Equivalents

$566M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$198M	$168M	+18.1%
Gross Profit	$93M	$39M	+140.6%
Operating Income	$19M	-$37M	+150.8%
Net Income	$13M	-$34M	+139.2%

Revenue Segments

Product

$198M100%